Statement of American Society of Nephrology (ASN) President Mark E. Rosenberg, MD, FASN, on Health and Human Services (HHS) Secretary Azar’s Announcement on Immunosuppressive Coverage for Kidney Transplants
American Society of Nephrology (ASN)On behalf of the more than 720,000 Americans with kidney failure whose lives depend on either a kidney transplant or dialysis to survive and their families, the 40 million Americans with kidney diseases, and the more than 20,000 ASN members who are physicians, scientists, nurses, and health professionals, ASN applauds the leadership of HHS Secretary Alex M. Azar, II, in confronting the issue of a three-year statutory restriction on Medicare coverage of immunosuppressant drugs following a kidney transplant. STATEMENT OF AMERICAN SOCIETY OF NEPHROLOGY (ASN) PRESIDENT MARK E. ROSENBERG, MD, FASN, ON HEALTH AND HUMAN SERVICES (HHS) SECRETARY AZAR’S ANNOUNCEMENT ON IMMUNOSUPPRESSIVE COVERAGE FOR KIDNEY TRANSPLANTS Washington, DC (March 15, 2019) – On behalf of the more than 720,000 Americans with kidney failure whose lives depend on either a kidney transplant or dialysis to survive and their families, the 40 million Americans with kidney diseases, and the more than 20,000 ASN members